Laura Fanning

2.1k total citations
26 papers, 446 citations indexed

About

Laura Fanning is a scholar working on Cardiology and Cardiovascular Medicine, Neurology and Epidemiology. According to data from OpenAlex, Laura Fanning has authored 26 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cardiology and Cardiovascular Medicine, 7 papers in Neurology and 6 papers in Epidemiology. Recurrent topics in Laura Fanning's work include Atrial Fibrillation Management and Outcomes (12 papers), Antiplatelet Therapy and Cardiovascular Diseases (5 papers) and Pharmaceutical Practices and Patient Outcomes (5 papers). Laura Fanning is often cited by papers focused on Atrial Fibrillation Management and Outcomes (12 papers), Antiplatelet Therapy and Cardiovascular Diseases (5 papers) and Pharmaceutical Practices and Patient Outcomes (5 papers). Laura Fanning collaborates with scholars based in Australia, United Kingdom and United States. Laura Fanning's co-authors include Ian Chi Kei Wong, Pajaree Mongkhon, Wallis C. Y. Lau, Chuenjid Kongkaew, Gary Tse, Elizabeth Manias, Nick K Jones, Li Wei, Jenni Ilomäki and J. Simon Bell and has published in prestigious journals such as PLoS ONE, Neurology and Neuroscience & Biobehavioral Reviews.

In The Last Decade

Laura Fanning

24 papers receiving 440 citations

Peers

Laura Fanning
Andrea López-López Spain
Bob G. Schultz United States
Bo‐Lin Ho Taiwan
Wanliang Du China
Yan Deschaintre Canada
Kuang-Wei Huang Taiwan
Xiaoqin Huang China
Hirotsugu Kanda Japan
Simon Bruce United States
Yuye Ning China
Andrea López-López Spain
Laura Fanning
Citations per year, relative to Laura Fanning Laura Fanning (= 1×) peers Andrea López-López

Countries citing papers authored by Laura Fanning

Since Specialization
Citations

This map shows the geographic impact of Laura Fanning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Fanning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Fanning more than expected).

Fields of papers citing papers by Laura Fanning

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Fanning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Fanning. The network helps show where Laura Fanning may publish in the future.

Co-authorship network of co-authors of Laura Fanning

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Fanning. A scholar is included among the top collaborators of Laura Fanning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Fanning. Laura Fanning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chary, Sowmya, Suma Babu, Gaëlle Bruneteau, et al.. (2025). Serious Neurologic Adverse Events in Tofersen Clinical Trials for Amyotrophic Lateral Sclerosis. Muscle & Nerve. 71(6). 1006–1015. 9 indexed citations
2.
3.
Petrie, Dennis, Anthony Harris, Laura Fanning, et al.. (2024). Developing and validating a discrete-event simulation model of multiple myeloma disease outcomes and treatment pathways using a national clinical registry. PLoS ONE. 19(8). e0308812–e0308812.
4.
Spinks, Jean, Douglas Boyle, Dennis Petrie, et al.. (2023). Activating pharmacists to reduce the frequency of medication‐related problems (ACTMed): a stepped wedge cluster randomised trial. The Medical Journal of Australia. 219(7). 325–331. 1 indexed citations
5.
Shaw, Pamela J., Timothy M. Miller, Merit Cudkowicz, et al.. (2022). Tofersen in adults with SOD1-ALS: phase 3 VALOR trial and open-label extension results. Journal of Neurology Neurosurgery & Psychiatry. 93(9). e2.208–e2.208. 3 indexed citations
6.
7.
Fanning, Laura, et al.. (2021). Cost-Effectiveness of Food Allergy Interventions in Children: A Systematic Review of Economic Evaluations. Value in Health. 24(9). 1360–1376. 10 indexed citations
8.
Bell, J. Simon, Dianna J. Magliano, Laura Fanning, et al.. (2021). Impact of Age, Frailty, and Dementia on Prescribing for Type 2 Diabetes at Hospital Discharge 2012–2016. The Journal of Frailty & Aging. 10(4). 343–349. 5 indexed citations
9.
Fanning, Laura, Wallis C. Y. Lau, Pajaree Mongkhon, et al.. (2020). Safety and Effectiveness of Direct Oral Anticoagulants vs Warfarin in People With Atrial Fibrillation and Dementia. Journal of the American Medical Directors Association. 21(8). 1058–1064.e6. 25 indexed citations
10.
Duncan, Gregory, Laura Fanning, David A. Taylor, et al.. (2020). Protocol for a randomised controlled trial evaluating the impact of a community pharmacy discharge medication reconciliation service on unplanned hospital readmissions – The DCMedsRec trial. Research in Social and Administrative Pharmacy. 17(2). 460–465. 1 indexed citations
11.
Mongkhon, Pajaree, Laura Fanning, Wallis C. Y. Lau, et al.. (2020). Oral anticoagulant and reduced risk of dementia in patients with atrial fibrillation: A population-based cohort study. Heart Rhythm. 17(5). 706–713. 56 indexed citations
12.
Fanning, Laura, Ian Chi Kei Wong, Xue Li, et al.. (2020). Gastrointestinal bleeding risk with rivaroxaban vs aspirin in atrial fibrillation: A multinational study. Pharmacoepidemiology and Drug Safety. 29(12). 1550–1561. 4 indexed citations
13.
Bryś, Mirosław, Laura Fanning, Serena Hung, et al.. (2019). Randomized phase I clinical trial of anti–α‐synuclein antibody BIIB054. Movement Disorders. 34(8). 1154–1163. 139 indexed citations
14.
Fanning, Laura, J. Simon Bell, Atte Meretoja, et al.. (2019). Prevalence, Safety, and Effectiveness of Oral Anticoagulant Use in People with and without Dementia or Cognitive Impairment: A Systematic Review and Meta-Analysis. Journal of Alzheimer s Disease. 71(4). 1375–1378. 2 indexed citations
15.
Ilomäki, Jenni, Laura Fanning, Claire Keen, et al.. (2019). Trends and Predictors of Oral Anticoagulant Use in People with Alzheimer’s Disease and the General Population in Australia. Journal of Alzheimer s Disease. 70(3). 733–745. 8 indexed citations
16.
Bryś, Mirosław, Aaron Ellenbogen, Laura Fanning, et al.. (2018). Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study of Anti-Alpha-Synuclein Antibody BIIB054 in Patients with Parkinson’s Disease (S26.001). Neurology. 90(15_supplement). 17 indexed citations
17.
Dalziel, Kim, John A Cheek, Laura Fanning, et al.. (2018). A Cost-Effectiveness Analysis Comparing Clinical Decision Rules PECARN, CATCH, and CHALICE With Usual Care for the Management of Pediatric Head Injury. Annals of Emergency Medicine. 73(5). 429–439. 15 indexed citations
18.
Mongkhon, Pajaree, Abdallah Y. Naser, Laura Fanning, et al.. (2018). Oral anticoagulants and risk of dementia: A systematic review and meta-analysis of observational studies and randomized controlled trials. Neuroscience & Biobehavioral Reviews. 96. 1–9. 57 indexed citations
19.
Fanning, Laura, J. Simon Bell, Atte Meretoja, et al.. (2018). Prevalence, Safety, and Effectiveness of Oral Anticoagulant Use in People with and without Dementia or Cognitive Impairment: A Systematic Review and Meta-Analysis. Journal of Alzheimer s Disease. 65(2). 489–517. 15 indexed citations
20.
Fanning, Laura, Jenni Ilomäki, J. Simon Bell, & Pēteris Dārziņš. (2017). The representativeness of direct oral anticoagulant clinical trials to hospitalized patients with atrial fibrillation. European Journal of Clinical Pharmacology. 73(11). 1427–1436. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrea López-López Breakdown of academic impact, for papers by Bob G. Schultz Breakdown of academic impact, for papers by Bo‐Lin Ho Breakdown of academic impact, for papers by Wanliang Du Breakdown of academic impact, for papers by Yan Deschaintre Breakdown of academic impact, for papers by Kuang-Wei Huang Breakdown of academic impact, for papers by Xiaoqin Huang Breakdown of academic impact, for papers by Hirotsugu Kanda Breakdown of academic impact, for papers by Simon Bruce Breakdown of academic impact, for papers by Yuye Ning
Rankless by CCL
2026